Retrieve Medical Holdings Inc. Announces Letter of Intent to Acquire Cúratus LLC, Strengthening AI-Powered Healthcare Solutions
Retrieve Medical Holdings has signed a Letter of Intent to acquire Cúratus , a Nevada-based technology company specializing in AI-driven provider data solutions. The acquisition will integrate Cúratus' SaaS platform, ProviderLenz, into Retrieve's healthcare solutions network.
The deal is subject to definitive agreement, closing conditions, public filings, and shareholder approval. Mark Fabiano, Cúratus' CEO and former Chief Sales Officer at Altegra Health, will continue leading the company as a subsidiary of Retrieve Medical Holdings.
ProviderLenz uses AI to aggregate and verify provider credentialing and directory data in real-time, addressing a critical issue in healthcare where credentialing errors and fraud contribute to over $100 billion in annual healthcare fraud costs. The merger aims to enhance operational efficiency, improve decision-making, and optimize patient care through advanced AI capabilities.
Retrieve Medical Holdings ha firmato una Lettera di Intenti per acquisire Cúratus, un'azienda tecnologica con sede in Nevada specializzata in soluzioni di dati per fornitori basate sull'AI. L'acquisizione integrerà la piattaforma SaaS di Cúratus, ProviderLenz, nella rete di soluzioni sanitarie di Retrieve.
Il contratto è soggetto a un accordo definitivo, condizioni di chiusura, registrazioni pubbliche e approvazione degli azionisti. Mark Fabiano, CEO di Cúratus e ex Chief Sales Officer di Altegra Health, continuerà a guidare l'azienda come sussidiaria di Retrieve Medical Holdings.
ProviderLenz utilizza l'AI per aggregare e verificare in tempo reale la qualificazione e i dati del direttorio dei fornitori, affrontando una questione critica nel settore sanitario dove gli errori di qualificazione e le frodi contribuiscono a oltre 100 miliardi di dollari di costi annuali per frodi sanitarie. La fusione mira a migliorare l'efficienza operativa, ottimizzare il processo decisionale e migliorare la cura dei pazienti attraverso capacità avanzate di AI.
Retrieve Medical Holdings ha firmado una Carta de Intención para adquirir Cúratus, una empresa tecnológica con sede en Nevada que se especializa en soluciones de datos para proveedores impulsadas por IA. La adquisición integrará la plataforma SaaS de Cúratus, ProviderLenz, en la red de soluciones de salud de Retrieve.
El acuerdo está sujeto a un contrato definitivo, condiciones de cierre, registros públicos y aprobación de los accionistas. Mark Fabiano, CEO de Cúratus y ex Director de Ventas en Altegra Health, continuará liderando la empresa como subsidiaria de Retrieve Medical Holdings.
ProviderLenz utiliza IA para agregar y verificar en tiempo real la acreditación y los datos del directorio de proveedores, abordando un problema crítico en el cuidado de la salud donde los errores de acreditación y el fraude contribuyen a más de 100 mil millones de dólares en costos anuales por fraude en salud. La fusión tiene como objetivo mejorar la eficiencia operativa, optimizar la toma de decisiones y mejorar la atención al paciente a través de capacidades avanzadas de IA.
Retrieve Medical Holdings는 AI 기반 공급자 데이터 솔루션을 전문으로 하는 네바다 소재 기술 회사 Cúratus를 인수하기 위한 의향서를 체결했습니다. 이번 인수는 Cúratus의 SaaS 플랫폼인 ProviderLenz를 Retrieve의 의료 솔루션 네트워크에 통합할 것입니다.
이 거래는 최종 계약, 마감 조건, 공개 서류 및 주주 승인에 따라 진행됩니다. Cúratus의 CEO이자 Altegra Health의 전 최고 영업 책임자인 Mark Fabiano는 Retrieve Medical Holdings의 자회사로서 회사를 계속 이끌 것입니다.
ProviderLenz는 AI를 사용하여 공급자의 자격 및 디렉토리 데이터를 실시간으로 집계하고 검증하여, 자격 오류와 사기가 연간 1,000억 달러 이상의 의료 사기 비용에 기여하는 의료 분야의 중요한 문제를 해결합니다. 이번 합병은 운영 효율성을 높이고 의사 결정을 개선하며 고급 AI 기능을 통해 환자 치료를 최적화하는 것을 목표로 합니다.
Retrieve Medical Holdings a signé une Lettre d'Intention pour acquérir Cúratus, une entreprise technologique basée au Nevada spécialisée dans les solutions de données pour les fournisseurs pilotées par l'IA. L'acquisition intégrera la plateforme SaaS de Cúratus, ProviderLenz, dans le réseau de solutions de santé de Retrieve.
L'accord est soumis à un contrat définitif, à des conditions de clôture, à des dépôts publics et à l'approbation des actionnaires. Mark Fabiano, PDG de Cúratus et ancien directeur des ventes chez Altegra Health, continuera à diriger l'entreprise en tant que filiale de Retrieve Medical Holdings.
ProviderLenz utilise l'IA pour agréger et vérifier en temps réel les qualifications et les données des annuaires des fournisseurs, abordant un problème critique dans le domaine de la santé où les erreurs de qualification et la fraude contribuent à plus de 100 milliards de dollars de coûts annuels de fraude en santé. La fusion vise à améliorer l'efficacité opérationnelle, à optimiser la prise de décision et à améliorer les soins aux patients grâce à des capacités avancées d'IA.
Retrieve Medical Holdings hat ein Absichtserklärung unterzeichnet, um Cúratus, ein in Nevada ansässiges Technologieunternehmen, das auf KI-gesteuerte Anbieter-Datenlösungen spezialisiert ist, zu erwerben. Die Übernahme wird die SaaS-Plattform von Cúratus, ProviderLenz, in das Gesundheitslösungsnetzwerk von Retrieve integrieren.
Der Deal steht unter dem Vorbehalt eines endgültigen Vertrags, von Abschlussbedingungen, öffentlichen Einreichungen und der Genehmigung durch die Aktionäre. Mark Fabiano, CEO von Cúratus und ehemaliger Chief Sales Officer bei Altegra Health, wird das Unternehmen weiterhin als Tochtergesellschaft von Retrieve Medical Holdings leiten.
ProviderLenz nutzt KI, um die Qualifikationen und Verzeichnisdaten von Anbietern in Echtzeit zu aggregieren und zu überprüfen, wodurch ein kritisches Problem im Gesundheitswesen angegangen wird, bei dem Qualifikationsfehler und Betrug zu über 100 Milliarden Dollar an jährlichen Betrugskosten im Gesundheitswesen beitragen. Die Fusion zielt darauf ab, die operative Effizienz zu steigern, die Entscheidungsfindung zu verbessern und die Patientenversorgung durch fortschrittliche KI-Funktionen zu optimieren.
- Integration of ProviderLenz platform addresses $100B+ healthcare fraud market
- Acquisition of proven leadership with CEO having previous exit experience ($900M)
- Strategic expansion into AI-driven provider data solutions
- Potential for operational cost reduction through AI automation
- Transaction subject to multiple approval conditions and uncertainties
- Integration costs and risks not disclosed
- Financial terms of acquisition not disclosed
BEDMINSTER, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Retrieve Medical Holdings Inc. (“Retrieve”), a Nevada corporation, today announced that it has signed a Letter of Intent (LOI) to acquire Cúratus LLC (“Curatus”), a Nevada-based technology company specializing in AI-driven provider data solutions. This strategic acquisition aims to enhance Retrieve’s portfolio by integrating Curatus’ innovative SaaS platform, ProviderLenz, into its growing network of healthcare solutions.
The transaction is contingent upon the finalization of a definitive agreement, the completion of customary closing conditions, including necessary public filings, and shareholder approval. This acquisition will combine the complementary strengths of both organizations, creating a more robust and forward-thinking entity positioned to drive growth and improve operational efficiency in the healthcare sector.
Following the acquisition, Mark Fabiano, CEO of Cúratus, is expected to continue leading the company as a wholly-owned subsidiary of Retrieve Medical Holdings. Prior to cofounding Cúratus, Mark served as Chief Sales Officer at Altegra Health, a provider of technology-enabled analytics services to that was grown to provide services nearly 200 regional and national payers before being acquired in 2015 for over
“We are thrilled to join forces with Retrieve Medical Holdings to revolutionize provider data management,” said Mark Fabiano, CEO of Cúratus. “This acquisition enables both companies to harness AI capabilities in innovative ways—driving operational efficiencies, improving decision-making, and ultimately optimizing patient care and satisfaction across the healthcare ecosystem.”
Curatus’ flagship platform, ProviderLenz, leverages AI to aggregate and verify provider credentialing and directory data in real-time, addressing the widespread issue of inaccurate provider data. Given that credentialing errors and fraud contribute to more than
The acquisition will empower both organizations to leverage advanced AI tools for automating routine tasks, enhancing data analysis, and creating tailored solutions that elevate customer experiences. With a shared commitment to AI, the combined entity will enable healthcare organizations to streamline their technology platforms, reduce administrative overhead, and gain a competitive advantage in an increasingly complex and rapidly changing industry.
About Retrieve Medical Holdings Inc.
Retrieve Medical Holdings, Inc. is transforming healthcare with its cutting-edge software platform, Retrieve Dx™. Using advanced natural language processing, Retrieve Dx™ analyzes patient data from multiple sources, helping physicians quickly understand complex clinical histories and diagnose chronic conditions. This technology integrates with leading electronic medical record systems such as Epic and Oracle Cerner, improving workflow, boosting patient outcomes, and increasing revenue for healthcare providers.
About Cúratus LLC
Founded in 2018 by Cory and Mark Fabiano and Jarrod Mandozzi, Cúratus is an innovative health IT company specializing in provider data management (PDM). Its AI-powered platform, ProviderLenz®, automates the distribution of accurate, up-to-date provider data across health plans and provider groups, improving efficiency, reducing costs, and enhancing compliance. In 2024, Cúratus was selected by one of the largest healthcare IT companies to integrate its PDM technology with leading healthcare claims platforms, enabling bi-directional, automated data exchange and further streamlining workflows across the healthcare ecosystem.
For more information, visit Retrieve Medical, Inc. at www.retrievemedical.com.
Contact info: Harriet Donnelly, CMO
Retrieve Medical, Inc.
908-392-3801
hdonnelly@retrievemedical.com
FAQ
What is the strategic importance of Retrieve Medical Holdings (RMHI) acquiring Cúratus?
When will the RMHI-Cúratus acquisition be completed?
What is the value of the Cúratus acquisition by RMHI?
How will ProviderLenz technology benefit RMHI's operations?
Who will lead Cúratus after the RMHI acquisition?
